The Alcohol & Drug Abuse Institute

Medication-First Delivery for High-Acuity Opioid Use Disorder Populations

This is multi-site, replication, implementation study of low-barrier buprenorphine access combined with care navigation to be delivered with community based service providers such as syringe exchanges, mobile medical clinics and homeless services providers.

Investigators

Caleb Banta-Green, PhD, MPH, MSW PI (UW ADAI)

Fund Information

The Paul G. Allen Family Foundation, Premera Blue Cross, Washington State Health Care Authority Division of Behavioral Health and Recovery
End: December 31, 2021
Status: current